REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 28 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 450 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 450 | -14.3% | 0.00% | – |
| Q3 2018 | $0 | – | 525 | -4.5% | 0.00% | – |
| Q2 2018 | $0 | – | 550 | +22.2% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 450 | -19.4% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 558 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 558 | -29.4% | 0.00% | – |
| Q2 2017 | $2,000 | – | 790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|